Primary leiomyosarcoma of kidney in a young adult by Pal, Dilip Kumar et al.
Vol 4 | Issue 6 | Nov - Dec 2018 Indian J Case Reports 441
Case Report
Primary leiomyosarcoma of kidney in a young adult
Dilip Kumar Pal1, Siddharth Saraf1, Pubali Mitra2, Suchandra Ray3
1Professor and Head, 2Post Doctoral Trainee, Department of Urology, 3Associate Professor, Department of Pathology, Institute of Post Graduate Medical 
Education and Research, Kolkata, West Bengal, India, 2Research Fellow, Department of Zoology, University of Calcutta, Kolkata, West Bengal, India
Correspondence to: Dilip Kumar Pal, Department of Urology, Institute of Post Graduate Medical Education and Research, 
Kolkata - 700020, India. E-mail: urologyipgmer@gmail.com
Received – 27 August 2018 Initial Review – 19 September 2018 Accepted – 03 November 2018
Primary sarcomas of the kidney represent 1–2% of all malignant tumors of kidney [1] and leiomyosarcoma (LMS) accounts for 60–70% of all sarcomas of the 
kidney. Females are more commonly affected usually in the 
4th–6th decades [2]. Flank pain, palpable mass, and hematuria 
constitute the major symptoms with the right side being more 
frequently affected [3]. A radical nephrectomy with wide 
margins is the treatment of choice for LMS of the kidney. 
However, the literature also supports treatment with partial 
nephrectomy in selected cases [4]. Here, we present the case 
of a 28-year-old female with primary LMS of the right kidney 
who underwent partial nephrectomy with a relevant review of 
the literature.
CASE REPORT
A 28-year-old female with no comorbidities reported to our 
department with chief complaints of intermittent, right-sided 
flank pain of 3 months duration. There was no history of any 
hematuria, gravelluria, or any altered bowel habits. On general 
physical examination, she was an average built, moderately 
nourished and was vitally stable. There was no palpable mass on 
per abdomen examination.
Her routine blood investigations were within normal limit. 
Contrast-enhanced computed tomography scan of the whole 
abdomen revealed a 3.6 cm × 3.2 cm × 2.8 cm mass in the lower 
pole of the right kidney with post-contrast enhancement and an 
R.E.N.A.L nephrometry score of 5a (Fig. 1).
She underwent partial nephrectomy. Postoperatively, the gross 
examination of the specimen revealed a globular mass 4 cm × 2 cm 
with infiltration of renal parenchyma and without the infiltration 
of the renal pelvis. All margins were free from tumor. The cut 
section revealed a fleshy tan mass with areas of necrosis and 
hemorrhage. On microscopic examination, the sections showed 
a well-encapsulated tumor composed of pleomorphic spindle-
shaped cells arranged in intersecting fascicles and showing 
whorled pattern at places with a mitotic count of 18–20/hpf 
(Fig. 2).
Immunohistochemistry was positive for desmin, vimentin, and 
smooth muscle actin (SMA) and negative for S100, cytokeratin 
(CK), CD99, CD56, and calretinin suggestive of leiomyosarcoma. 
The patient has undergone a whole body positron emission 
tomography scan at 3 months interval and is free of any residual 
or recurrent tumor until 1 year of follow-up. The patient is under 
close follow-up in oncology and urology department.
DISCUSSION
LMS is a rare tumor that arises most commonly from smooth 
muscle of soft tissues and uterine tissue. In a majority of the 
cases, renal LMS arises from smooth muscle of renal vessels 
but can also arise from the renal pelvis and renal capsule [5]. 
The incidence of the primary LMS of the kidney increases 
with age, more commonly affecting females and the right 
kidney [5].
Renal LMS is less common but more lethal than LMS 
of other genitourinary sites such as prostate, bladder, and 
paratesticular region [6]. The symptoms increase with the 
advancing disease stage. The pressure effect results in flank 
pain and hematuria and it sometimes presents with a palpable 
mass. Nausea, vomiting, and abdominal pain may occur as a 
part of systemic symptoms [5]. It is difficult to differentiate 
LMS of the kidney from renal cell carcinoma (RCC) as they 
exhibit similar clinical, radiological, and pathological features. 
ABSTRACT
Primary renal leiomyosarcoma (LMS) is an extremely rare tumor constituting to <2% of all malignant renal tumors. Here, we 
present the case of a 28-year-old female with a right lower polar renal tumor, who underwent partial nephrectomy which on 
microscopy suggested LMS. Due to the lack of a follow-up protocol and low survival rates, regular imaging and a multidisciplinary 
approach were considered in the patient.
Key words: Kidney, Leiomyosarcoma, Partial nephrectomy, Young adult
Pal et al. Leiomyosarcoma of kidney
Vol 4 | Issue 6 | Nov - Dec 2018 Indian J Case Reports 442
The differentiating features being size, site of origin, and lymph 
nodal involvement. Renal LMS tends to displace rather than 
invade the renal parenchyma and has a rapid growth rate. They 
also tend to have frequent metastasis and high local and systemic 
recurrence rates [7].
Sarcomatoid RCC forms the closest differential diagnosis 
of renal LMS [8]. In case of fast-growing masses, sarcomas 
should always be considered. The sarcomas possess a 
pseudocapsule which is often found to be infiltrated by the 
tumor. On histopathology, thorough sampling for an absence of 
any epithelial component should be done to rule out sarcomatoid 
RCC. On immunohistochemistry, LMS tumor cells are positive 
for desmin, SMA calponin, H-caldesmon, and negative for CK, 
S-100, and HMB-45. The angiomyolipoma shows positivity for 
HMB-45 while CK positivity is seen in a sarcomatoid variant of 
RCC [9].
In a study done by Lewis et al., unresectable disease and 
positive surgical margins were reported as the most significant 
factors predictive of disease-specific mortality [10]. The initial 
resection tends to be the key and gives the best chance for a 
long-term cure [11]. Radical nephrectomy with wide margins 
is recommended in patients with renal LMS. However, partial 
nephrectomy has also been given as the form of treatment in the 
literature [4,12].
According to the statistical records of the National Cancer 
Institute and American Joint Committee on Cancer, only 50% of 
the patients live longer than 5 years. With increasing grade, this 
survival rate drops further. In general, it is seen that there is no 
survival advantage of neoadjuvant or adjuvant chemoradiation 
in LMS [3,6]. However, in a study, adjuvant chemotherapy has 
been seen to be beneficial in partially resected tumors [13]. 
Kamba et al. showed that neoadjuvant chemotherapy with 
(cyclophosphamide, vincristine, adriamycin, and dacarbazine) 
can cause downstaging of the tumor and increases the possibility 
of complete resection [14].
Deyrup et al. demonstrated that increasing histological grade 
was a poor prognostic factor [7]. Primary LMS of the kidney 
is associated with significantly poor prognosis as compared 
to other renal malignancies. A detailed morphological and 
immunohistochemical analysis is required for its diagnosis 
and management [15]. To accomplish better oncologic control, 
neoadjuvant and adjuvant treatment modalities should be 
considered. As no follow-up protocol has been devised due to 
the paucity of cases, stringent imaging should be considered for 
follow-up in such cases, and the patients with renal LMS should 
be referred for multidisciplinary management.
CONCLUSION
Primary LMS of the kidney is rare, but an important tumor that 
may present similarly to other renal malignancies. A high index of 
suspicion should be maintained due to the non-specific symptoms. 
Although radical nephrectomy is the gold standard treatment for 
renal LMS, our patient being treated with partial nephrectomy is 
also supported in some reports.
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